Enhancing the Evaluation of Acute Ischemic Stroke Risk in Individuals with Non-valvular Atrial Fibrillation by Including Laboratory Indicators

Overview

Journal Sci Rep

Specialty Science

Date 2024 Mar 22

PMID 38514850

Authors

Xin Hou

Xiaohong Zhang

Affiliations

Soon will be listed here.

Abstract

To investigate the clinical significance of the CHADS-VASc-60 score, lipoprotein (a) [Lp(a)], red blood cell distribution width (RDW), and their combined effect in patients with non-valvular atrial fibrillation (NVAF) who experience acute ischemic stroke (AIS). This retrospective analysis was conducted on the clinical data of hospitalized patients with NVAF at the Third Affiliated Hospital of Anhui Medical University between April 1, 2020, and April 1, 2023. Based on the diagnosis of acute ischemic stroke (AIS), the patients were divided into two groups: the AIS group (150 cases of NVAF patients with comorbid AIS) and the non-AIS group (163 cases of NVAF patients without AIS). We performed CHADS-VASc-60 scoring for all patients and collected their laboratory indicators and echocardiographic indicators during hospitalization. The study comprised 313 individuals with NVAF in total. There is a statistically significant difference (P < 0.05) in the comparison of CHADS-VASc-60 score (5.68 ± 1.12 vs. 3.67 ± 1.47), Lp(a) [23.98 (13.28, 42.22) vs. 14.32 (7.96, 21.91)] and RDW (13.67 ± 1.25 vs. 12.94 ± 0.76) between NVAF patients with and without concomitant AIS. The results of the Spearman correlation analysis demonstrate a positive association between Lp(a) and RDW levels and both the CHADS-VASc score and the CHADS-VASc-60 score in patients with NVAF. Multivariate logistic regression analysis revealed that CHADS-VASc-60 score [OR = 6.549, 95% CI: 4.110-10.433, P < 0.05], Lp(a) [OR = 1.023, 95% CI: 1.005-1.041, P < 0.05], and RDW [OR = 1.644, 95% CI: 1.071-2.525, P < 0.05] were independent risk factors for AIS in patients with non-valvular atrial fibrillation (NVAF). The receiver operator characteristic (ROC) curves showed that the area under the curve of CHADS-VASc-60 score, Lp(a), RDW, and CHADS-VASc-60 score combined with Lp(a) and RDW predicted that NVAF patients with AIS were 0.881 [95% CI: 0.804-0.906], 0.685 [95% CI: 0.626-0.744], 0.695 [95% CI: 0.637-0.754], and 0.906 [95% CI: 0.845-0.921], respectively. The CHADS-VASc-60 score, Lp(a), and RDW were significantly increased in NVAF patients with AIS, which were independent risk factors for NVAF patients with AIS. The combination of the three has a high predictive capacity for NVAF patients with AIS.

References

Aronis K, Zhao D, Hoogeveen R, Alonso A, Ballantyne C, Guallar E . Associations of Lipoprotein(a) Levels With Incident Atrial Fibrillation and Ischemic Stroke: The ARIC (Atherosclerosis Risk in Communities) Study. J Am Heart Assoc. 2017; 6(12). PMC: 5779047. DOI: 10.1161/JAHA.117.007372. View

Ding W, Protty M, Davies I, Lip G . Relationship between lipoproteins, thrombosis, and atrial fibrillation. Cardiovasc Res. 2021; 118(3):716-731. PMC: 8859639. DOI: 10.1093/cvr/cvab017. View

Adamsson Eryd S, Borne Y, Melander O, Persson M, Smith J, Hedblad B . Red blood cell distribution width is associated with incidence of atrial fibrillation. J Intern Med. 2013; 275(1):84-92. DOI: 10.1111/joim.12143. View

Ezratty A, Simon D, Loscalzo J . Lipoprotein(a) binds to human platelets and attenuates plasminogen binding and activation. Biochemistry. 1993; 32(17):4628-33. DOI: 10.1021/bi00068a021. View

Li N, Zhou H, Tang Q . Red Blood Cell Distribution Width: A Novel Predictive Indicator for Cardiovascular and Cerebrovascular Diseases. Dis Markers. 2017; 2017:7089493. PMC: 5606102. DOI: 10.1155/2017/7089493. View

Kim T, Yang P, Yu H, Jang E, Uhm J, Kim J . Age Threshold for Ischemic Stroke Risk in Atrial Fibrillation. Stroke. 2018; 49(8):1872-1879. DOI: 10.1161/STROKEAHA.118.021047. View

Hamatani Y, Ogawa H, Takabayashi K, Yamashita Y, Takagi D, Esato M . Left atrial enlargement is an independent predictor of stroke and systemic embolism in patients with non-valvular atrial fibrillation. Sci Rep. 2016; 6:31042. PMC: 4971566. DOI: 10.1038/srep31042. View

Caplice N, Panetta C, Peterson T, Kleppe L, Mueske C, Kostner G . Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis. Blood. 2001; 98(10):2980-7. DOI: 10.1182/blood.v98.10.2980. View

Arnold M, Schweizer J, Nakas C, Schutz V, Westphal L, Inauen C . Lipoprotein(a) is associated with large artery atherosclerosis stroke aetiology and stroke recurrence among patients below the age of 60 years: results from the BIOSIGNAL study. Eur Heart J. 2021; 42(22):2186-2196. DOI: 10.1093/eurheartj/ehab081. View

10.

Sacco R, Kasner S, Broderick J, Caplan L, Connors J, Culebras A . An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013; 44(7):2064-89. PMC: 11078537. DOI: 10.1161/STR.0b013e318296aeca. View

11.

Zhan X, Lin W, Liu F, Xue Y, Liao H, Li X . Predictive value of red cell distribution width on left atrial thrombus or left atrial spontaneous echo contrast in patients with non-valvular atrial fibrillation. J Geriatr Cardiol. 2018; 15(6):408-412. PMC: 6087520. DOI: 10.11909/j.issn.1671-5411.2018.06.007. View

12.

Alkhouli M, Friedman P . Ischemic Stroke Risk in Patients With Nonvalvular Atrial Fibrillation: JACC Review Topic of the Week. J Am Coll Cardiol. 2019; 74(24):3050-3065. DOI: 10.1016/j.jacc.2019.10.040. View

13.

Saliba W, Barnett-Griness O, Elias M, Rennert G . The association between red cell distribution width and stroke in patients with atrial fibrillation. Am J Med. 2014; 128(2):192.e11-8. DOI: 10.1016/j.amjmed.2014.09.020. View

14.

Kodani E, Akao M . Atrial fibrillation and stroke prevention: state of the art-epidemiology and pathophysiology: new risk factors, concepts and controversies. Eur Heart J Suppl. 2020; 22(Suppl O):O1-O13. PMC: 7753870. DOI: 10.1093/eurheartj/suaa176. View

15.

Bhatia H, Yeang C, Baruch A, Yang X, Stroes E, Tsimikas S . PCSK9 Inhibition and Oxidized Phospholipids. J Am Coll Cardiol. 2021; 78(12):1288-1289. PMC: 10198455. DOI: 10.1016/j.jacc.2021.07.031. View

16.

da Silva R, Borges L . Neutrophil-Lymphocyte Ratio and Red Blood Cell Distribution Width in Patients with Atrial Fibrillation and Rheumatic Valve Disease. Curr Vasc Pharmacol. 2023; 21(6):367-377. DOI: 10.2174/1570161121666230726123444. View

17.

Zhang J, Johnsen S, Guo Y, Lip G . Epidemiology of Atrial Fibrillation: Geographic/Ecological Risk Factors, Age, Sex, Genetics. Card Electrophysiol Clin. 2021; 13(1):1-23. DOI: 10.1016/j.ccep.2020.10.010. View

18.

Cha M, Lee H, Kim H, Jung J, Choi E, Oh S . Association between red cell distribution width and thromboembolic events in patients with atrial fibrillation. Eur J Intern Med. 2017; 46:41-46. DOI: 10.1016/j.ejim.2017.07.028. View

19.

Hald E, Lochen M, Lappegard J, Ellingsen T, Mathiesen E, Wilsgaard T . Red Cell Distribution Width and Risk of Atrial Fibrillation and Subsequent Thromboembolism: The Tromsø Study. TH Open. 2020; 4(3):e280-e287. PMC: 7521943. DOI: 10.1055/s-0040-1716417. View

20.

Saxena R, Lewis S, Berge E, Sandercock P, Koudstaal P . Risk of early death and recurrent stroke and effect of heparin in 3169 patients with acute ischemic stroke and atrial fibrillation in the International Stroke Trial. Stroke. 2001; 32(10):2333-7. DOI: 10.1161/hs1001.097093. View